NASDAQ:TLPH Talphera (TLPH) Stock Price, News & Analysis → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free TLPH Stock Alerts $1.04 +0.05 (+5.05%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$1.00▼$1.0450-Day Range$0.93▼$1.3852-Week Range$0.43▼$1.61Volume31,676 shsAverage Volume112,962 shsMarket Capitalization$17.67 millionP/E RatioN/ADividend YieldN/APrice Target$4.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get Talphera alerts: Email Address Talphera MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside334.2% Upside$4.50 Price TargetShort InterestHealthy0.65% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.33Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.12) to ($1.06) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.33 out of 5 starsMedical Sector483rd out of 905 stocksPharmaceutical Preparations Industry221st out of 422 stocks 3.5 Analyst's Opinion Consensus RatingTalphera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageTalphera has only been the subject of 2 research reports in the past 90 days.Read more about Talphera's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.65% of the float of Talphera has been sold short.Short Interest Ratio / Days to CoverTalphera has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Talphera has recently decreased by 6.75%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTalphera does not currently pay a dividend.Dividend GrowthTalphera does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TLPH. Previous Next 1.9 News and Social Media Coverage News SentimentTalphera has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Talphera this week, compared to 14 articles on an average week.Search InterestOnly 2 people have searched for TLPH on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows3 people have added Talphera to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Talphera insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.00% of the stock of Talphera is held by insiders.Percentage Held by InstitutionsOnly 37.67% of the stock of Talphera is held by institutions.Read more about Talphera's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Talphera are expected to grow in the coming year, from ($1.12) to ($1.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Talphera is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Talphera is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTalphera has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Talphera's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> About Talphera Stock (NASDAQ:TLPH)Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.Read More TLPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TLPH Stock News HeadlinesMay 8, 2024 | americanbankingnews.comMaxim Group Initiates Coverage on Talphera (NASDAQ:TLPH)May 6, 2024 | msn.comMaxim Group Initiates Coverage of Talphera (TLPH) with Buy RecommendationMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.May 2, 2024 | prnewswire.comTalphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024April 25, 2024 | finance.yahoo.comTalphera, Inc. (TLPH)April 13, 2024 | finance.yahoo.comTalphera, Inc. (TLPH) Stock Historical Prices & Data - Yahoo FinanceMarch 21, 2024 | msn.com5 years after it was yanked off stores, GOG's bringing underrated spy RPG Alpha Protocol in from the cold with fewer crashes and new achievementsMarch 20, 2024 | msn.comAlpha Protocol Finally Available Again Five Years After Being DelistedMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.March 20, 2024 | seekingalpha.comTaysha: Initial Rett Syndrome Data Leads To Other 2024 CatalystsMarch 20, 2024 | msn.comCult classic spy RPG Alpha Protocol is back on PC after being delisted in 2019March 20, 2024 | msn.comAlpha Violet Propels ‘Identifying Features’ Directors’ Unconventional Sundance-Winning Cartel Narrative ‘Sujo’ to Cross Borders (EXCLUSIVE)March 20, 2024 | msn.comWolf Dogs vs. Alpha Academy stipulation match announced for next WWE NXTMarch 20, 2024 | msn.comAlpha Group: fintech reports growth as it eyes premium listing in 2024March 20, 2024 | msn.comUpcoming WWE NXT: Breakker and Corbin Team Up Against Alpha AcademyMarch 19, 2024 | msn.comMMOs collide as one fan recreates RuneScape using World of Warcraft assets, and after 9 months of work is getting close to an honest-to-god alpha buildMarch 19, 2024 | msn.comDonald Trump looks 'power-riddled' as he tries to be the 'alpha' in interview with Nigel FarageMarch 19, 2024 | finance.yahoo.comDubai-based Cryptocurrency Venture Capital 'Alpha Token Capital' Invests in $CVTXMarch 19, 2024 | msn.comGen Alpha-geared Brand Subdued Gets InvestmentMarch 19, 2024 | msn.comWhat Is Generation Alpha? Meaning, Characteristics, and FutureMarch 19, 2024 | msn.comVindictus: Defying Fate Preview: Visually Stunning Pre-Alpha PlaytestMarch 18, 2024 | msn.comUnderstanding the Alpha Female: A Guide to Embracing Your Inner LeaderMarch 18, 2024 | msn.comElectoral Bonds Case: 'SBI has to reveal and present the alpha numeric number' says Supreme CourtMarch 18, 2024 | msn.comElectoral Bonds: What Are Unique Alpha-Numeric Numbers Asked By Supreme Court From SBI?March 18, 2024 | msn.comElectoral Bonds Data 2nd List LIVE: ASSOCHAM, FICCI and other industry organisations filed an application seeking deferment of hearing on SBI alpha numerical numbersMarch 17, 2024 | msn.comDonald Trump wanted to create an 'alpha rough guy presence' during unhinged 'bloodbath' speechMarch 16, 2024 | msn.comAlpha’s patriotic fundraiser prepares for the 4th of JulySee More Headlines Receive TLPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/06/2024Today5/08/2024Next Earnings (Confirmed)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:TLPH Previous SymbolNASDAQ:TLPH CUSIPN/A CIK1427925 Webtalphera.com Phone650-216-3500Fax650-216-6500Employees15Year FoundedN/APrice Target and Rating Average Stock Price Target$4.50 High Stock Price Target$6.00 Low Stock Price Target$3.00 Potential Upside/Downside+332.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,400,000.00 Net MarginsN/A Pretax Margin-1,580.18% Return on Equity-71.67% Return on Assets-46.65% Debt Debt-to-Equity RatioN/A Current Ratio2.56 Quick Ratio2.56 Sales & Book Value Annual Sales$651,000.00 Price / Sales27.15 Cash FlowN/A Price / Cash FlowN/A Book Value$0.83 per share Price / Book1.25Miscellaneous Outstanding Shares16,993,000Free Float16,483,000Market Cap$17.67 million OptionableOptionable Beta0.46 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Vincent J. Angotti (Age 56)CEO & Director Comp: $906.54kDr. Pamela Pierce Palmer M.D. (Age 61)Ph.D., Co-Founder & Chief Medical Officer Comp: $699.75kMr. Raffi Mark Asadorian (Age 55)Chief Financial Officer Comp: $637.5kMr. Anil N. Dasu (Age 61)Chief Engineering Officer Comp: $478.09kKey CompetitorsNeuroSense TherapeuticsNASDAQ:NRSNIndaptus TherapeuticsNASDAQ:INDPAytu BioPharmaNASDAQ:AYTUVBI VaccinesNASDAQ:VBIVNeuroBo PharmaceuticalsNASDAQ:NRBOView All Competitors TLPH Stock Analysis - Frequently Asked Questions Should I buy or sell Talphera stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Talphera in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TLPH shares. View TLPH analyst ratings or view top-rated stocks. What is Talphera's stock price target for 2024? 2 equities research analysts have issued 1 year target prices for Talphera's shares. Their TLPH share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.50 in the next twelve months. This suggests a possible upside of 334.2% from the stock's current price. View analysts price targets for TLPH or view top-rated stocks among Wall Street analysts. How have TLPH shares performed in 2024? Talphera's stock was trading at $0.7989 at the beginning of the year. Since then, TLPH stock has increased by 29.7% and is now trading at $1.0363. View the best growth stocks for 2024 here. When is Talphera's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our TLPH earnings forecast. How can I listen to Talphera's earnings call? Talphera will be holding an earnings conference call on Tuesday, May 14th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Talphera's earnings last quarter? Talphera, Inc. (NASDAQ:TLPH) announced its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.01. The company earned $0.28 million during the quarter. How do I buy shares of Talphera? Shares of TLPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TLPH) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
